Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-02-01

Clinical Trial Update: Effects Of Gamma Aminobutyric Acid On The Progression Of New Onset Juvenile Type 1 Diabetes [NA]

View source ↗

Summary

This clinical trial assesses whether gamma-aminobutyric acid (GABA) influences the progression of new-onset juvenile Type 1 diabetes; the current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gamma-aminobutyric acid (gamma-aminobutyric acid)

Snippet

Sponsor: Huashan Hospital | Conditions: Type 1 Diabetes | NA | Status: UNKNOWN